Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast

from pharmaphorum Podcast · host pharmaphorum

In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this month. Francis was previously CEO of Sandoz, Novartis’ generics and biosimilars division, where he led the development of biosimilars and also sat on the Swiss pharma company’s executive committee.

Episode metadata supplied by the publisher feed · Published Feb 12, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast

0:00 14:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 14 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on February 12, 2021.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!